Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 68180-606

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 68180-606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1c99f2f2 C07c 45a1 B18f 64a3ee505190 01

Chemical structure of Clonidine Hydrochloride, showing a bicyclic ring system with two chlorine atoms and an attached imidazoline ring with a hydrochloride moiety.*

FDA Label Image

1c99f2f2 C07c 45a1 B18f 64a3ee505190 02

A pharmacokinetic graph comparing mean plasma concentration (pg/mL) over time (hours) for Clonidine Hydrochloride extended-release tablets under fasted and fed conditions, and Catapres under fasted conditions. The graph shows changes in drug concentration from 0 to 48 hours post-dose.*

FDA Label Image

1c99f2f2 C07c 45a1 B18f 64a3ee505190 03

A Kaplan-Meier survival curve comparing treatment failure rates over time between Clonidine Hydrochloride Extended-Release Tablets and placebo. The x-axis represents days from randomization to treatment failure, and the y-axis shows the estimated proportion of patients with treatment failure. The graph includes censored data points and distinguishes between the two treatment groups with solid and dashed lines.*

FDA Label Image

1c99f2f2 C07c 45a1 B18f 64a3ee505190 04

Label for Clonidine Hydrochloride Extended-Release Tablets USP 0.1 mg, oral dosage form, produced by Lupin Pharmaceuticals, Inc. The label states the product is prescription only, comes in a 30-tablet package, and includes storage instructions and manufacturers' details from Lupin Pharmaceuticals in Baltimore, MD, and Lupin Limited in Nagpur, India. The NDC number 68180-606 is visible.*

FDA Label Image

1c99f2f2 C07c 45a1 B18f 64a3ee505190 05

Label for Clonidine Hydrochloride Extended-Release Tablets USP 0.1 mg, oral extended-release tablets. The label shows the NDC number 68180-606-07, indicates the package contains 60 tablets, and is labeled by Lupin Pharmaceuticals, Inc. Storage instructions and manufacturing details for Lupin Limited, India, are also included.*

FDA Label Image

1c99f2f2 C07c 45a1 B18f 64a3ee505190 06

Label for Clonidine Hydrochloride Extended-Release Tablets USP 0.1 mg by Lupin Pharmaceuticals, Inc. The label states the tablets are for oral use, extended-release, containing 0.1 mg clonidine hydrochloride. The package contains 90 tablets and includes storage instructions and manufacturing details for Lupin Pharmaceuticals in Baltimore, Maryland, and Lupin Limited in Nagpur, India. The NDC number is 68180-606-09.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.